The Section of medicinal products for human:
Section of medicinal products for human, including API, medication intermediates related to the API provided by the company, and formulations., is combined with Zhejiang Guobang Pharmaceutical Co., Ltd., Zhejiang Dongying Pharmaceutical Co., Ltd., Zhejiang Zhongtong Pharmaceutical Co., Ltd., Zhejiang Guobang Xiandai Medicine Co., Ltd.,Shandong Guobang Pharmaceutical Co., Ltd.
API production is the core section of the company. At the same time, the company handle the production of the medication intermediates upstream of the industrial chain and the produce of the formulation downstream. The company is the leading producer and supporter of macrolides API and quinolone API. Guobang Pharma plays the most significant roles in the production ability and market sharing of these antibiotics. The bulk API products contain azithromycin，clarithromycin, roxithromycin, ciprofloxacin series, and cephalosporins, and the special APIs include Azelnidipine and Fudosteine. In the section of medication intermediates, the company mainly focus on the reductant products. The company also produces Sodium borohydride, potassium borohydride, N-methyl piperazine, N-ethyl piperazine, and cyclopropylamine, which not only can offer strong support to the production on the rural materials but also have the significant place in the global market sharing.
The main products produced by Guobang Pharma earn the international compliance market certifications such as the certification of FDA, EUGMP,REACH,CEP, PMDA, ANVISA, and MFDS. Furthermore, products also gain medical and food certifications for people who have specific demands such as KOSHER and HALA.
The section of animal health:
The section of animal health contains API for animals, addictive, and formulation, and is combined with Zhejiang Guobang Pharmaceutical Co., Ltd., Shandong Guobang Pharmaceutical Co., Ltd., Xinchang Hebao Biotechnology Co., Ltd., Zhejiang Guobang Pharmaceutical Co., Ltd. used to take part in the compiling of the Chinese veterinary pharmacopoeia. Xinchang Hebao Biotechnology Co., Ltd is an famous veterinary drugs producer, top 50 animal health company, and it is also one of the vice presidents of CAHPA.
The products of API for animals contain veterinary antibiotics (florfenicol, the series of enrofloxacin, and marbofloxacin，Sarafloxacin, Dapfloxacin), and insects-resistant drug (diclazuril, and cyromazine). The formulation products include premix, powder, granules, and taste-masking. Addictive products contain different vitamin powder (VA, VE, VD3). The company maintains the largest export volume of enrofloxacin API in China for nearly three years. In 2019, the company also gained the largest export volume of florfenicol in China.